Quince Therapeutics
QNCX
#9491
Rank
C$72.15 M
Marketcap
$1.64
Share price
4.89%
Change (1 day)
12.57%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -$1.12

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.15. In 2022 the company made an earnings per share (EPS) of -$2.19 an increase over its 2021 EPS that were of -$4.20.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.12-48.73%
2022-$2.19-47.85%
2021-$4.2015.21%
2020-$3.6462.51%
2019-$2.24179.56%
2018-$0.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.02 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA